Business Context and Reporting Period
This Form 8-K Current Report is filed by Bristol-Myers Squibb Company for the reporting period ending November 30, 2005. The filing primarily addresses corporate governance changes regarding the appointment of principal officers.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding personnel changes and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the promotion of John E. Celentano to President, Health Care Group, effective November 30, 2005. Mr. Celentano, 45, previously served as President, Latin America and Canada, for the Company's pharmaceutical business. His prior roles include President, Canada, Mexico and the Caribbean; Vice President and General Manager, Northern Europe; and General Manager, Puerto Rico and the Caribbean.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document focuses exclusively on the executive appointment and includes a press release as an exhibit.
Key Facts for Investor Verification
- John E. Celentano was promoted to President, Health Care Group, effective November 30, 2005.
- The appointment was made by the Compensation and Management Development Committee.
- A press release dated December 2, 2005, is attached as Exhibit 99.1.
- No financial data or forward-looking guidance is included in this specific filing.